Evaluating the management of urinary tract infections by community pharmacists in Queensland, Australia
Main Article Content
Keywords
urinary tract infections, health services accessibility, primary health care, clinical audit
Abstract
Background: While workloads of general practitioners (family physicians) can be supported by allied health professionals treating minor ailments, there is a need to evaluate the quality of these primary care interventions. In Queensland, Australia, appropriately trained community pharmacists provided empirical management of uncomplicated urinary tract infections to people with a biologic female urinary tract, between 18-65 years of age using a structured model of care. Objective: The aim was to determine whether community pharmacists can safely and effectively manage uncomplicated urinary tract infections. Methods: A prospective, observational, mixed-methods evaluation was designed to collect data over an 18-month period. People with a biologic female urinary tract, between the ages of 18-65 years, who presented to a community pharmacy, and met the symptom definition of an uncomplicated urinary tract infection, and agreed to participate in the study, were included. Results: A total of 10,270 instances of service provision were analysed. These services were recorded by 588 pharmacies that delivered at least one service. Follow-up data were available for 28.9% (2,973/10,270) services. Most (93.0%) were prescribed 3-days of trimethoprim as per the structured model of care and of those followed-up 87.6% reported resolution of symptoms following antibiotic treatment. For eighty five follow-up consultations (2.9%), patients indicated experiencing adverse events from antibiotic treatment. Five patients visited an emergency department, and upon review by doctors on the Steering Advisory Group, pharmacists were found to have followed the structured model of care in all cases. Conclusion: This study provides evidence that provision of antibiotics by appropriately trained pharmacists using a structured model of care was safe and effective. Given the rise in antimicrobial resistance worldwide, regular audits of prescribing by all health practitioners are recommended.
References
2. Beahm NP, DJ Smyth, RT Tsuyuki. Outcomes of Urinary Tract Infection Management by Pharmacists (RxOUTMAP): A study of pharmacist prescribing and care in patients with uncomplicated urinary tract infections in the community. Can Pharm J (Ott).
2018;151(5):305-14. https://doi.org/10.1177/1715163518781175
3. Stewart F, Caldwell G, Cassells K, Burton J, Watson A. Building capacity in primary care: the implementation of a novel ‘Pharmacy First’ scheme for the management of UTI, impetigo and COPD exacerbation. Prim Health Care Res Dev. 2018;19(6):531-41.
https://doi.org/10.1017/s1463423617000925
4. Booth JL, Mullen AB, Thomson DAM, Johnstone C, Galbraith SJ, Bryson SM, McGovern EM. Antibiotic treatment of urinary tract infection by community pharmacists: a cross-sectional study. Br J Gen Pract. 2013;63(609):e244-9. https://doi.org/10.3399/
bjgp13x665206
5. Gauld NJ, Zeng IS, Ikram RB, Thomas MG, Buetow SA. Antibiotic treatment of women with uncomplicated cystitis before and after allowing pharmacist-supply of trimethoprim. Int J Clin Pharm. 2017;39(1):165-72. https://doi.org/10.1007/s11096-016-0415-1
6. Health Workforce Queensland, 2021 Health Workforce Needs Assessment: Summary of the primary care workforce needs in remote and rural Queensland. 2021, Health Workforce Queensland Brisbane, Australia. Available at: https://www.healthworkforce.com.au/blog/2021/08/2021-health-workforce-needs-assessment-now available?source=google.com Accessed 27/10/2023
7. Wozniak TM, Dyda A, Lee X. The Increased Length of Hospital Stay and Mortality Associated With Community-Associated Infections in Australia. Open Forum Infect Dis. 2022;9(5):ofac133. https://doi.org/10.1093/ofid/ofac133
8. Little P, Moore M, Turner S, Rumsby K, Warner G, Lowes JA, et al. Effectiveness of five different approaches in the management of urinary tract infection: a randomised controlled trial. BMJ. 2010;340:c199. https://doi.org/10.1136/bmj.c199
9. Sathiananthamoorthy S, Malone-Lee J, Gill K, Tymon A, Nguyen TK, Gurung S, et al. Reassessment of routine midstream culture in diagnosis of urinary tract infection. J Clin Microbiol. 2019;57(3):e01452-18. https://doi.org/10.1128/jcm.01452-18
10. Scottish Intercollegiate Guidelines Network (SIGN), Management of suspected bacterial lower urinary tract infection in adult women, in SIGN publication number 160. 2020, Scottish Intercollegiate Guidelines Network: Edinburgh, Scotland. Available at:
https://www.sign.ac.uk/our-guidelines/management-of-suspected-bacterial-lower-urinary-tract-infection-in-adult-women/Accessed 27/10/2023
11. Jarvis TR, L Chan, T Gottlieb. Assessment and management of lower urinary tract infection in adults. Aust Prescr. 2014;37(1):7-9.
12. Bent S, Nallamothu BK, Simel D, Fihn SD, Saint S. Does This Woman Have an Acute Uncomplicated Urinary Tract Infection? JAMA. 2002;287(20):2701-0. https://doi.org/10.1001/jama.287.20.2701
13. Australian Therapeutic Guidelines, Antibiotic choice for urinary tract infection in adults. 2019.
14. National Institute for Health and Care Excellence (NICE), Urinary tract prescribing (lower): antimicrobial prescribing in NICE guidelines [NG109]. 2018. Available at: https://www.nice.org.uk/guidance/ng109 Accessed 27/10/2023
15. Gupta K, Hooton TM, Naber KG, Wullt B, Colgan R, Miller LG, et al. Infectious Diseases Society of America; European Society for Microbiology and Infectious Diseases, International clinical practice guidelines for the treatment of acute uncomplicated
cystitis and pyelonephritis in women: A 2010 update by the Infectious Diseases Society of America and the European Society for Microbiology and Infectious Diseases. Clin Infect Dis.2011;52(5):e103-20. https://doi.org/10.1093/cid/ciq257
16. Queensland Government. Interesting facts about Queensland. 2022 11/04/2022]; Available at: https://www.qld.gov.au/about/about-queensland/statistics-facts Accessed 27/10/2023
17. Harper A, et al. Inquiry into the establishment of a pharmacy council and transfer of pharmacy ownership in Queensland. Report No. 12, 56th Parliament Health, Communities, Disability Services and Domestic and Family Violence Prevention
Committee October 2018. Available at: https://documents.parliament.qld.gov.au/tableOffice/TabledPapers/2018/5618T1639.
pdf Accessed 27/10/2023
18. Queensland Government. Response to the Health, Communities, Disability Services and Domestic and Family Violence Prevention Committee’s Report No. 12 – Inquiry into the establishment of a pharmacy council and transfer of pharmacy
ownership in Queensland. Tabled April 16, 2019. Available at: https://cabinet.qld.gov.au/documents/2019/Apr/RespRep12/Attachments/Response.PDF Accessed 27/10/2023
19. Nissen L, Lau E, Spinks J, The management of urinary tract infections by community pharmacists: A state-wide trial, in Urinary Tract Infection Pharmacy Pilot – Queensland (Service Evaluation Report). 2023, Queensland Health: Brisbane, Australia.
Available at: https://eprints.qut.edu.au/239310/ Accessed 27/10/2023
20. Nissen L, Lau E, & Spinks J, The management of urinary tract infections by community pharmacists: A state-wide trial: Urinary Tract Infection Pharmacy Pilot - Queensland (Outcome Report). 2022, Queensland Health: Brisbane, Australia. Available at:
https://eprints.qut.edu.au/232923/ Accessed 27/20/2023
21. Pharmaceutical Society of New Zealand. Urinary tract infections management accreditation training. 2022, Available at: https://www.psnz.org.nz/Product?Action=View&Product_id=824 Accessed 27/10/2023
22. Pharmaceutical Society of Australia (2016). National Competency Standards Framework for Pharmacists in Australia. 2013. PSA, Deakin West, ACT. 23. Australian Pharmacy Council Available at: https://www.psa.org.au/wp-content/uploads/2018/06/
National-Competency-Standards-Framework-for-Pharmacists-in-Australia-2016-PDF-2mb.pdf Accessed 27/10/2023
23. Australian Pharmacy Council. Accreditation Standards for Continuing Professional Development Activities. Canberra, ACT. Available at: https://www.pharmacycouncil.org.au/resources/accreditation-standards-for-cpd/ Accessed 27/10/2023
24. Queensland Government. Medicines and Poisons Act 2019: Extended Practice Authority ‘Pharmacists’. 2022. Brisbane, Queensland. Available at: https://www.health.qld.gov.au/__data/assets/pdf_file/0027/1108944/epa-pharmacists.pdf
Accessed 27/10/2023
25. StataCorp, Stata Statistical Software: Release 17, StataCorp, Editor. 2021: College Station, TX.
26. Australian Government Department of Health and Aged Care. The Modified Monash Model. Available at: https://www.health.gov.au/topics/rural-health-workforce/classifications/mmm#about-the-modified-monash-model Accessed 27/10/2023
27. Australian Government Department of Health. Modified Monash Model Fact Sheet. Available at: https://www.health.gov.au/sites/default/files/documents/2020/07/modified-monash-model-fact-sheet.pdf Accessed 27/10/2023
28. Outbreak Consortium. OUTBREAK – A One Health antimicrobial resistance economic perspective. 2020. Sydney, Australia: UTS. Available at: https://outbreakproject.com.au/wp-content/uploads/2020/12/OUTBREAK_REPORT_2020_economics_
ERRATUM.pdf Accessed 27/10/2023
29. Australian Commission on Safety and Quality in Health Care. AURA 2021: Fourth Australian report on antimicrobial use and resistance in human health. 2021. Sydney: Australia. Available at: https://www.safetyandquality.gov.au/our-work/
antimicrobial-resistance/antimicrobial-use-and-resistance-australia-surveillance-system/aura-2021 Accessed 27/10/2023
30. Medina M, Castillo-Pino E. An introduction to the epidemiology and burden of urinary tract infections. Ther Adv Urol. 2019;11:1756287219832172. https://doi.org/10.1177/1756287219832172
31. Morrissey H, Ball P, Jackson D, Pilloto L, Nielsen S. Viability and sustainability of pharmacist input in chronic disease management in rural Australia. J Pharm Pract Res. 2015;45:262-71. https://doi.org/10.1002/jppr.1089
32. Christiaens TC, De Meyere M, Verschraegen G, Peersman W, Heytens S, De Maeseneer JM. Randomised controlled trial of nitrofurantoin versus placebo in the treatment of uncomplicated urinary tract infection in adult women. Br J Gen
Pract.2002;52(482):729-34. http://www.ncbi.nlm.nih.gov/pmc/articles/pmc1314413/
33. Ferry SA, Holm SE, Stenlund H, Lundholm R, Monsen TJ. Clinical and bacteriological outcome of different doses and duration of pivmecillinam compared with placebo therapy of uncomplicated lower urinary tract infection in women: the LUTIW project.
Scand J Prim Health Care. 2007;25(1):49-57. https://doi.org/10.1080/02813430601183074
34. Richards D, Toop L, Chambers S, Fletcher L. Response to antibiotics of women with symptoms of urinary tract infection but negative dipstick urine test results: double blind randomised controlled trial. BMJ. 2005;331(7509):143. https://doi.
org/10.1136/bmj.38496.452581.8f
35. Little P, Merriman R, Turner S, Rumsby K, Warner G, Lowes JA, et al. Presentation, pattern, and natural course of severe symptoms, and role of antibiotics and antibiotic resistance among patients presenting with suspected uncomplicated urinary
tract infection in primary care: observational study. BMJ. 2010;340: b5633 https://doi.org/10.1136/bmj.b5633
36. Yeung EYH, Mohammed RSD. Pharmacists prescribed 7 times more antibiotics than physicians did for query urinary tract infection. Can Pharm J (Ott). 2019;152(5):281-2. https://doi.org/10.1177/1715163519866223
37. Sihra N, Goodman A, Zakri R, Sahai A, Malde S, Nonantibiotic prevention and management of recurrent urinary tract infection. Nat Rev Urol. 2018;15:750-76. https://doi.org/10.1038/s41585-018-0106-x